Kuipers Peter J. 4
4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Feb 2, 2026
Research Summary
AI-generated summary of this filing
Clover Health (CLOV) CFO Peter Kuipers Withholds 156,856 Shares
What Happened
- Peter J. Kuipers, Chief Financial Officer of Clover Health Investments, had 156,856 shares of Class A common stock withheld on January 29, 2026 to cover tax obligations tied to RSU vesting. The shares were valued at $2.31 each, a total value of approximately $362,337. This was a withholding to satisfy taxes upon vesting, not an open‑market sale.
Key Details
- Transaction date: 2026-01-29; Filing date: 2026-02-02 (timely)
- Price per share: $2.31; Shares withheld/disposed: 156,856; Aggregate value ≈ $362,337
- Reason: Automatic share withholding to cover tax liabilities on 6.25% of the original time‑based RSU grant awarded April 29, 2024 (see footnote)
- Remaining RSUs vest in equal quarterly installments with a final vesting date of April 29, 2028, subject to continued service
- Shares owned after transaction: not specified in the provided filing excerpt
- Transaction code: F (tax withholding), which is a routine administrative disposition rather than a market sale or purchase
Context
- This transaction represents a common corporate practice where a portion of vested RSUs are retained by the company to satisfy withholding taxes; it does not necessarily indicate a change in the insider’s view of the company. For investors, purchases often carry more signaling value than routine tax withholdings.
Insider Transaction Report
Form 4
Kuipers Peter J.
Chief Financial Officer
Transactions
- Tax Payment
Class A Common Stock
[F1]2026-01-29$2.31/sh−156,856$362,337→ 5,758,353 total
Footnotes (1)
- [F1]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 29, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2024. The remaining RSUs vest in equal quarterly installments, with a final vesting date on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date.
Signature
Peter J. Rivas as attorney-in-fact for Peter Kuipers|2026-02-02